← 返回

口腔舌鳞状细胞癌宿主免疫微环境的组织学评估及其预后意义:淋巴细胞宿主反应 (LHR) 与 TIL(肿瘤浸润淋巴细胞)(TILs) 的比较研究

英文原题:Histologic evaluation of host immune microenvironment and its prognostic significance in oral tongue squamous cell carcinoma: a comparative study on lymphocytic host response (LHR) and tumor infiltrating lymphocytes (TILs).

查看英文原题

Histologic evaluation of host immune microenvironment and its prognostic significance in oral tongue squamous cell carcinoma: a comparative study on lymphocytic host response (LHR) and tumor infiltrating lymphocytes (TILs).

PubMed 2021/05/10(内容时间) Pathol Res Pract Q1 · IF 3.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

与定性的 LHR 分级方案相比,sTIL 似乎是评估宿主免疫微环境更优的定量组织学指标。

中文摘要

宿主免疫微环境是抗肿瘤免疫反应的重要组成部分,会影响肿瘤进展、消退及治疗反应。常规组织病理诊断需要简单可靠的组织学指标来测量宿主免疫反应。

在一项回顾性研究中,对329例口腔舌鳞状细胞癌(OTSCC)患者(肿瘤直径≤4 cm)进行比较,评估淋巴细胞宿主反应(LHR,这是一种定性组织学分级方案)的预后价值,并与间质/瘤内TIL(肿瘤浸润淋巴细胞)(sTIL/iTIL)百分比这一定量指标比较。

单因素生存分析显示,较高的sTIL预示更好的远处复发无生存期;多因素分析显示其为总生存期改善的独立预后因素。LHR和iTIL与淋巴结转移风险或结局无关。

与定性的LHR分级方案相比,sTIL似乎是衡量宿主免疫微环境的更优定量组织学指标。sTIL是OTSCC总生存期的独立预后因素。

展开英文摘要原文

Host immune microenvironment is a key component of anti-tumoral immune response, influencing tumor progression, regression, and treatment responses. There is a need for simple and reliable histologic measurements of host immune response in routine histopathologic diagnosis.

The prognostic value of lymphocytic host response (LHR), a qualitative histologic grading scheme, was compared to stromal/intratumoral TIL (sTIL/iTIL) percentage, a quantitative measurement in a retrospective study of 329 patients with oral tongue squamous cell carcinoma (OTSCC) of 4 cm or less in size.

High sTIL predicted improved distant recurrence free survival on univariate survival analysis and was an independent prognostic factor for better overall survival on multivariate analysis. LHR and iTIL were not associated with the risk of nodal metastasis or outcome.

sTIL appears to be a superior quantitative histologic measurement for the host immune microenvironment compared with the qualitative LHR grading scheme. sTIL is an independent prognostic factor for overall survival in OTSCC.

论文信息

作者
Xu B、Salama AM、Valero C、Yuan A、Khimraj A、Saliba M、Zanoni DK、Ganly I
第一作者单位
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.United States
通讯作者单位
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: katabin@mskcc.org.United States
文献类型
对照研究
期刊
Pathology, research and practice2021 Dec
原文标识
PubMed 34059347 · DOI 10.1016/j.prp.2021.153473